GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer

Clinical trial NCT00089856 · TERMINATED

Trial details

NCT number: NCT00089856
Sponsor: Cell Genesys
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2004-07-01
Primary completion: 2008-10-01
Enrollment: 626

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.